Effect of poly (2-methoxyethyl acrylate)-coated oxygenators on haemolysis

M Kocakulak1, T Ozgürtaş, H Ayhan

  • 1Başkent University, Biomedical Engineering Department, PK 48, 06592 Ankara, Turkey. mustafak@baskent.edu.tr

Insights

Poly(2-methoxyethyl acrylate) (PMEA) coating on medical devices significantly reduces blood cell damage and free hemoglobin release during extracorporeal circulation. This biocompatible coating enhances safety by minimizing hemolysis in blood-contacting artificial surfaces.

Area of Science:

  • Biomaterials Science
  • Medical Device Engineering
  • Hematology

Background:

  • Hemolysis, or red blood cell damage, is a critical concern with artificial devices due to blood contact and mechanical trauma.
  • Poly(2-methoxyethyl acrylate) (PMEA) is an amphiphilic polymer known for its positive effects on blood-device interactions.
  • Previous studies suggest PMEA coatings improve protein adsorption, reduce platelet loss, and decrease post-operative bleeding.

Purpose of the Study:

  • To investigate the impact of PMEA-coated oxygenators on hemolysis during cardiopulmonary bypass (CPB).
  • To quantify the reduction in blood cell damage and related markers with PMEA-coated devices compared to non-coated ones.

Main Methods:

  • Utilized PMEA-coated (SX18-Capiox) and non-coated oxygenators in a study setting.
  • Measured desorbed free hemoglobin, erythrocyte counts, and bilirubin levels (direct and indirect) at multiple time points during and after CPB.
  • Analyzed blood aliquots at baseline, during CPB, end of CPB, post-protamine injection, and in intensive care.

Main Results:

  • Hemolysis rates were within clinically acceptable ranges for both coated and non-coated oxygenators.
  • Average desorbed free hemoglobin was significantly lower with PMEA-coated oxygenators (6663 mg/dl) compared to non-coated (29,405 mg/dl).
  • Lower levels of indirect bilirubin and a less pronounced decrease in erythrocyte count were observed with PMEA-coated devices, indicating reduced red blood cell damage.

Conclusions:

  • PMEA coating effectively reduces red blood cell damage during extracorporeal circulation.
  • The study demonstrates a clear relationship between PMEA coating and reduced hemolysis at blood-contacting surfaces.
  • PMEA-coated oxygenators offer enhanced hemocompatibility, improving safety during CPB procedures.